Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%

Last updated: March 1, 2020
Sponsor: Farid Masoud
Overall Status: Completed

Phase

3

Condition

Alopecia

Hair Loss

Male Pattern Baldness

Treatment

N/A

Clinical Study ID

NCT03753113
TabrizUMS
  • Ages 18-50
  • Male
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is evaluating the efficacy and safety of a topical herbal solution in males for the treatment of Androgenetic alopecia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Men 18 to 50 years old

  • Written consent

  • Normal general health status

  • Men who have a presentation of androgenetic alopecia (Norwood II - V).

Exclusion

Exclusion Criteria:

  • Use of any topical product in the target region interfering with the study product inthe last three months

  • Within the past 6 months receiving of chemotherapy/cytotoxic agents

  • Clinical diagnosis of alopecia areata or other non-AGA forms of alopecia

  • Uncontrolled hypertension

  • Any dermatological disorders in the scalp, such as fungal or bacterial infections,eczema, atopic dermatitis, seborrheic dermatitis, psoriasis, sun damage, skin cancer

  • Hormonal diseases such as thyroid disorders, diabetes and, ...

  • Smokers

  • Liver and kidney disease

  • History of hair transplants

  • History of surgical correction of hair loss on the scalp

  • Subject having dyed, bleached hair or, with a permanent wave prior to study start.

  • No written consent

Study Design

Total Participants: 24
Study Start date:
November 28, 2018
Estimated Completion Date:
September 02, 2019

Study Description

This study will be done on male subjects with Androgenetic alopecia(AGA). The patients will be selected by volunteers attending the Dermatology department of Sina Hospital, and eligible individuals will be selected among them. Subjects were randomized to use either Topical Herbal Solution or Topical Minoxidil 5% for 36 weeks.

To our knowledge, this herbal solution for the first time covers all four major causes of AGA, including the 5α-reductase enzyme, androgen receptors, paracrine agents that affecting dermal papilla and hair cell apoptosis processes. Therefore it acts with the quadruple mechanism. The application of this new herbal solution for the treatment of AGA should be recommended.

Connect with a study center

  • Department of Dermatology, Sina Hospital

    Tabriz, East Azerbaijan
    Iran, Islamic Republic of

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.